[1] E.-M. Mandelkow, E. Mandelkow, Biochemistry and cell biology of tau protein in neurofibrillary degeneration, Cold Spring Harbor perspectives in medicine (2012) a006247.
[2] N.V. Gorantla, A.V. Shkumatov, S. Chinnathambi, Conformational Dynamics of Intracellular Tau Protein Revealed by CD and SAXS, Tau Protein, Springer2017, pp. 3-20.
[3] K. Iqbal, A.d.C. Alonso, S. Chen, M.O. Chohan, E. El-Akkad, C.-X. Gong, S. Khatoon, B. Li, F. Liu, A. Rahman, Tau pathology in Alzheimer disease and other tauopathies, Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1739(2-3) (2005) 198-210.
[4] S.K. Sonawane, S. Chinnathambi, Prion-Like Propagation of Post-Translationally Modified Tau in Alzheimer’s Disease: A Hypothesis, Journal of Molecular Neuroscience 65(4) (2018) 480-490.
[5] T. Mitchison, L. Cramer, Actin-based cell motility and cell locomotion, Cell 84(3) (1996) 371-379.
[6] J.R. Bamburg, G.S. Bloom, Cytoskeletal pathologies of Alzheimer disease, Cell motility and the cytoskeleton 66(8) (2009) 635.
[7] N.J. Cairns, V.M.Y. Lee, J.Q. Trojanowski, The cytoskeleton in neurodegenerative diseases, The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland 204(4) (2004) 438-449.
[8] J.A. Hadfield, S. Ducki, N. Hirst, A.T. McGown, Tubulin and microtubules as targets for anticancer drugs, Progress in Cell Cycle Research. 5 (2003) 309-326.
[9] J.V. Small, T. Stradal, E. Vignal, K. Rottner, The lamellipodium: where motility begins, Trends in cell biology 12(3) (2002) 112-120.
[10] T. Stepanova, J. Slemmer, C.C. Hoogenraad, G. Lansbergen, B. Dortland, C.I. De Zeeuw, F. Grosveld, G. van Cappellen, A. Akhmanova, N. Galjart, Visualization of microtubule growth in cultured neurons via the use of EB3-GFP (end-binding protein 3-green fluorescent protein), Journal of Neuroscience 23(7) (2003) 2655-2664.
[11] C. Ballatore, V.M.-Y. Lee, J.Q. Trojanowski, Tau-mediated neurodegeneration in Alzheimer's disease and related disorders, Nature Reviews Neuroscience 8(9) (2007) 663.
[12] A.A. Balmik, S. Chinnathambi, Multi-faceted role of melatonin in neuroprotection and amelioration of Tau aggregates in Alzheimer’s disease, Journal of Alzheimer's Disease 62(4) (2018) 1481-1493.
[13] N.V. Gorantla, V.G. Landge, P.G. Nagaraju, P. Priyadarshini CG, E. Balaraman, S. Chinnathambi, Molecular cobalt (II) complexes for tau polymerization in Alzheimer’s disease, ACS omega 4(16) (2019) 16702-16714.
[14] I. Khlistunova, J. Biernat, Y. Wang, M. Pickhardt, M. von Bergen, Z. Gazova, E. Mandelkow, E.-M. Mandelkow, Inducible expression of Tau repeat domain in cell models of tauopathy aggregation is toxic to cells but can be reversed by inhibitor drugs, Journal of Biological Chemistry 281(2) (2006) 1205-1214.
[15] N.V. Gorantla, R. Das, F.A. Mulani, H.V. Thulasiram, S. Chinnathambi, Neem Derivatives Inhibits Tau Aggregation, Journal of Alzheimer's Disease Reports 3(1) (2019) 169-178.
[16] M. Pickhardt, Z. Gazova, M. von Bergen, I. Khlistunova, Y. Wang, A. Hascher, E.-M. Mandelkow, J. Biernat, E. Mandelkow, Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells, Journal of Biological Chemistry 280(5) (2005) 3628-3635.
[17] S.K. Sonawane, A.A. Balmik, D. Boral, S. Ramasamy, S. Chinnathambi, Baicalein suppresses Repeat Tau fibrillization by sequestering oligomers, Archives of Biochemistry and Biophysics 675 (2019) 108119.
[18] B.I. Lee, Y.S. Suh, Y.J. Chung, K. Yu, C.B. Park, Shedding light on Alzheimer’s β-amyloidosis: photosensitized methylene blue inhibits self-assembly of β-amyloid peptides and disintegrates their aggregates, Scientific reports 7(1) (2017) 7523.
[19] J.S. Lee, B.I. Lee, C.B. Park, Photo-induced inhibition of Alzheimer's β-amyloid aggregation in vitro by rose bengal, Biomaterials 38 (2015) 43-49.
[20] M. Kostelanska, J. Freisleben, Z. Backovska Hanusova, T. Mosko, R. Vik, D. Moravcova, A. Hamacek, J. Mosinger, K. Holada, Optimization of the photodynamic inactivation of prions by a phthalocyanine photosensitizer: the crucial involvement of singlet oxygen, Journal of biophotonics (2019) e201800340.
[21] G. Leshem, M. Richman, E. Lisniansky, M. Antman-Passig, M. Habashi, A. Gräslund, S.K. Wärmländer, S. Rahimipour, Photoactive chlorin e6 is a multifunctional modulator of amyloid-β aggregation and toxicity via specific interactions with its histidine residues, Chemical science 10(1) (2019) 208-217.
[22] G.K. Wilcock, S. Gauthier, G.B. Frisoni, J. Jia, J.H. Hardlund, H.J. Moebius, P. Bentham, K.A. Kook, B.O. Schelter, D.J. Wischik, Potential of low dose leuco-methylthioninium bis (hydromethanesulphonate)(LMTM) monotherapy for treatment of mild Alzheimer’s disease: Cohort analysis as modified primary outcome in a phase III clinical trial, Journal of Alzheimer's Disease 61(1) (2018) 435-457.
[23] B.-L. Sun, W.-W. Li, C. Zhu, W.-S. Jin, F. Zeng, Y.-H. Liu, X.-L. Bu, J. Zhu, X.-Q. Yao, Y.-J. Wang, Clinical research on Alzheimer’s disease: progress and perspectives, Neuroscience bulletin 34(6) (2018) 1111-1118.
[24] K. Biberoglu, M.Y. Tek, S.T. Ghasemi, O. Tacal, Toluidine blue O is a potent inhibitor of human cholinesterases, Archives of biochemistry and biophysics 604 (2016) 57-62.
[25] N.V. Gorantla, E. Balaraman, S. Chinnathambi, Cobalt-based metal complexes prevent Repeat Tau aggregation and nontoxic to neuronal cells, International Journal of Biological Macromolecules (2020).
[26] N.V. Gorantla, R. Das, E. Balaraman, S. Chinnathambi, Transition metal nickel prevents Tau aggregation in Alzheimer's disease, International journal of biological macromolecules (2019).
[27] S.K. Sonawane, A. Ahmad, S. Chinnathambi, Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer’s Disease, ACS Omega 4(7) (2019) 12833-12840.
[28] N.V. Gorantla, S. Chinnathambi, Tau Protein Squired by Molecular Chaperones During Alzheimer’s Disease, Journal of Molecular Neuroscience 66(3) (2018) 356-368.
[29] K. Iqbal, F. Liu, C.-X. Gong, Tau and neurodegenerative disease: the story so far, Nature Reviews Neurology 12(1) (2016) 15.
[30] N.V. Gorantla, V.G. Landge, P.G. Nagaraju, L.P. Sunny, A. Nair, S.P. Midya, P. Priyadarshini, B. Ekambaram, S. Chinnathambi, Molecular Complexes for Effective Inhibition of Tau Aggregation, bioRxiv (2018) 363572.
[31] C. Marshall, S. Clunas, J.M.D. Storey, J.P. Sinclair, T.C. Baddeley, A. Ishaq, M. Simpson, C. Williamson, B.A. Wood, C.M. Wischik, Phenothiazine diaminium salts and their use, Google Patents, 2019.
[32] M. Oz, D.E. Lorke, G.A. Petroianu, Methylene blue and Alzheimer's disease, Biochemical pharmacology 78(8) (2009) 927-932.
[33] E. Poteet, A. Winters, L.-J. Yan, K. Shufelt, K.N. Green, J.W. Simpkins, Y. Wen, S.-H. Yang, Neuroprotective actions of methylene blue and its derivatives, PloS one 7(10) (2012) e48279.
[34] G. Sridharan, A.A. Shankar, Toluidine blue: A review of its chemistry and clinical utility, Journal of oral and maxillofacial pathology: JOMFP 16(2) (2012) 251.
[35] T.M. Dimauro, M. Attawia, S. Lilienfeld, C. Holy, Intranasal red light probe for treating Alzheimer's disease, Google Patents, 2008.
[36] T.M. Dimauro, M. Attawia, C. Holy, S. Lilienfeld, J.K. Sutton, M. Ward, Red light implant for treating Parkinson's disease, Google Patents, 2007.
[37] D.M. Johnstone, C. Moro, J. Stone, A.-L. Benabid, J. Mitrofanis, Turning on lights to stop neurodegeneration: the potential of near infrared light therapy in Alzheimer's and Parkinson's disease, Frontiers in neuroscience 9 (2016) 500.
[38] M. Sharma, L. Visai, F. Bragheri, I. Cristiani, P.K. Gupta, P. Speziale, Toluidine blue-mediated photodynamic effects on staphylococcal biofilms, Antimicrobial agents and chemotherapy 52(1) (2008) 299-305.
[39] M. Yuksel, K. Biberoglu, S. Onder, K.G. Akbulut, O. Tacal, Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease, Biochimie 146 (2018) 105-112.
[40] M. Wainwright, D.A. Phoenix, L. Rice, S.M. Burrow, J. Waring, Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation, Journal of Photochemistry and Photobiology B: Biology 40(3) (1997) 233-239.
[41] Y.-H. Liu, C.-C. Ho, C.-C. Cheng, Y.-H. Hsu, Y.-S. Lai, Photoradiation could influence the cytoskeleton organization and inhibit the survival of human hepatoma cells in vitro, Lasers in medical science 21(1) (2006) 42.
[42] L. Luo, Actin cytoskeleton regulation in neuronal morphogenesis and structural plasticity, Annual review of cell and developmental biology 18(1) (2002) 601-635.
[43] A. Mallavarapu, T. Mitchison, Regulated actin cytoskeleton assembly at filopodium tips controls their extension and retraction, The Journal of cell biology 146(5) (1999) 1097-1106.